CD4 and neoplasm: Oliveira et al. investigated on the phenotype and clonotype of infiltrating CD4+ T cells in melanoma, illustrating how tumor-specific CD4+ TILs with different HLA expressions could engage with tumor cells to induce antitumor responses in TME.